J Gen Virol Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beringue, V.
Right arrow Articles by Dormont, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beringue, V.
Right arrow Articles by Dormont, D.
Agricola
Right arrow Articles by Beringue, V.
Right arrow Articles by Dormont, D.

Journal of General Virology, Vol 80, 1873-1877, Copyright © 1999 by Society for General Microbiology

ARTICLES

Inhibiting scrapie neuroinvasion by polyene antibiotic treatment of SCID mice

V Beringue, CI Lasmezas, KT Adjou, R Demaimay, F Lamoury, JP Deslys, M Seman and D Dormont
CEA, Service de Neurovirologie, DSV/DRM, CRSSA, 60--68 av. Division Leclerc, BP 6, 92265 Fontenay aux Roses Cedex, France

The polyene antibiotic MS-8209 is currently one of the most effective drugs in the treatment of experimental scrapie. However, its mechanism of action and its site of intervention in the pathogenetical process of scrapie infection are largely unknown. It has been shown previously that the infection of immunodeficient SCID mice by the peripheral route provides a reliable model for direct scrapie neuroinvasion, bypassing the lymphoreticular system. Indeed, a proportion of SCID mice develop scrapie after a similar time to immunocompetent mice, despite their severe immune impairment. This model is now used to clarify the targets of MS-8209. In SCID mice, MS-8209 treatment protected against infection but did not prolong survival time. In SCID mice immunologically reconstituted prior to inoculation, the drug delayed the disease without an effect on the attack rate. These findings strongly suggest that MS-8209 acts by hampering the first step of the neuroinvasion process, i.e. the uptake of the infectious agent by peripheral nerve endings. The mechanism leading to the inhibition of agent propagation to nervous cells is discussed with regard to the properties of polyene antibiotics.


This article has been cited by other articles:


Home page
 BrainHome page
C. R Trevitt and J. Collinge
A systematic review of prion therapeutics in experimental models
Brain, September 1, 2006; 129(9): 2241 - 2265.
[Abstract] [Full Text] [PDF]

Home page
 Br Med BullHome page
D. Dormont
Approaches to prophylaxis and therapy: An investigation into prion disease diversity
Br. Med. Bull., June 1, 2003; 66(1): 281 - 292.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
P. Brown
Drug therapy in human and experimental transmissible spongiform encephalopathy
Neurology, June 25, 2002; 58(12): 1720 - 1725.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
V. Beringue, K. T. Adjou, F. Lamoury, T. Maignien, J.-P. Deslys, R. Race, and D. Dormont
Opposite Effects of Dextran Sulfate 500, the Polyene Antibiotic MS-8209, and Congo Red on Accumulation of the Protease-Resistant Isoform of PrP in the Spleens of Mice Inoculated Intraperitoneally with the Scrapie Agent
J. Virol., June 15, 2000; 74(12): 5432 - 5440.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1999 by the Society for General Microbiology.